Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study

Wide-scale profiling technologies including metabolomics broaden the possibility of novel discoveries related to the pathogenesis of type 2 diabetes (T2D). By applying non-targeted metabolomics approach, we investigated here whether serum metabolite profile predicts T2D in a well-characterized study...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mello, Vanessa D., Paananen, Jussi, Lindström, Jaana, Lankinen, Maria A., Shi, Lin, Kuusisto, Johanna, Pihlajamäki, Jussi, Auriola, Seppo, Lehtonen, Marko, Rolandsson, Olov, Bergdahl, Ingvar A., Nordin, Elise, Ilanne-Parikka, Pirjo, Keinänen-Kiukaanniemi, Sirkka, Landberg, Rikard, Eriksson, Johan G., Tuomilehto, Jaakko, Hanhineva, Kati, Uusitupa, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387722/
https://www.ncbi.nlm.nih.gov/pubmed/28397877
http://dx.doi.org/10.1038/srep46337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387722/
https://www.ncbi.nlm.nih.gov/pubmed/28397877
http://dx.doi.org/10.1038/srep46337

Ejemplares similares